ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันอาทิตย์ที่ ๒๓ กรกฎาคม พ.ศ. ๒๕๖๐ ๑๙:๔๘ น.

Food and Healthcare Press Releases

Do you know new repellent technology INSECT SHIELD was now launched in Thailand Heathcare—๒๑ ก.ค. ๖๐

INSECT SHIELD was developed in USA since 1996 at a request by US Military to terminate Lyme Disease brought by Ticks. As a result of 7 years testing and experiments, now US Army and Marine adopts INSECT SHIELD technology to their uniforms. INSECT SHIELD

Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting from Dompe Research for the Treatment of Moderate to Severe Neurotrophic Keratitis is Made in Italy Heathcare—๒๑ ก.ค. ๖๐

MILAN--21 Jul--PRNewswire/InfoQuest

Dompe, an Italian biopharmaceutical company, announces that the European Commission has granted the marketing authorisation of cenegermin eye drops for the treatment of moderate to severe neurotrophic keratitis. This makes it the first biotechnological treatment authorized for this specific indication in the Europe Union, which responds to the needs of patients affected by this rare and severely debilitating eye disease that can cause vision loss. Until now, there have been no approved drugs for the treatment of this condition.

(Logo: http://mma.prnewswire.com/media/531470/Dompe_Logo.jpg )
(Photo: http://mma.prnewswire.com/media/531471/Dompe.jpg )
Behind the development of cenegermin are decades of "Made in Italy" research, stemming from the studies of Nobel laureate Rita Levi Montalcini, who discovered

Global Health Services Company Cigna Acquires Zurich Insurance Middle Heathcare—๑๒ ก.ค. ๖๐

Cigna launches new phase of operations as the premier provider of health and wellness services to Individuals, Employers and Government entities across the Middle East Cigna Corporation (NYSE: CI), a global health services company, today announced the

ALK - Five-year GRAZAX(R) Asthma Prevention (GAP) Trial Reveals Benefits of Early Treatment Heathcare—๗ ก.ค. ๖๐

- The disease modifying property of GRAZAX(R) (SQ(R) grass SLIT-tablet) resulted in long-term effect on allergic rhinoconjunctivitis (ARC) and prevented asthma symptoms, even two years after end of treatment in children with grass pollen ARC and no

Merck Awards EUR1.25 Million to Research Projects Through its 2017 Grant for Fertility Innovation Heathcare—๕ ก.ค. ๖๐

- The company is committed to driving innovation through evolving the product portfolio and investing in potential breakthrough research Merck, a leading science and technology company, today announced its commitment to award EUR1.25 million to research

UMIT Private University for Health Sciences Medical Informatics and Technology: Results of a Heathcare—๔ ก.ค. ๖๐

A simulation study published in BMC Public Health by researchers of the Tyrolean Health and Life Sciences University UMIT, the Oncotyrol center, the Medical University of Innsbruck and the University of Toronto highlights optimized use of prostate cancer

New Analysis Reveals First-Line Treatment Data on SIR-Spheres(R) Y-90 Resin Microspheres for Heathcare—๓ ก.ค. ๖๐

SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic colorectal cancer (mCRC) patients with right-sided primary

Novo Nordisk to Present 35 Abstracts at the International Society on Thrombosis and Haemostasis Heathcare—๓ ก.ค. ๖๐

Novo Nordisk announced today that data from 35 abstracts will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) congress from 8-13 July, in Germany. This data will be featured across posters, abstracts and oral

Singapore#s Healthcare Leaders will Gather to Realize its Healthcare 2020 Heathcare—๒๗ มิ.ย. ๖๐

Singapore and regional healthcare leaders will gather at HIMSS AsiaPac17 from 11 – 14 September at the Marina Bay Sands. Themed Team-Based Care: Unifying Patients and Providers , Guest of Honour Senior Minister of State Chee Hong Tat, Ministry of

Neovii: Long-term Outcomes After Standard Graft-Versus-Host Disease (GvHD) Prophylaxis in Heathcare—๒๖ มิ.ย. ๖๐

- The 8-year follow-up results of a randomized phase 3 multicenter trial in adult patients with hematologic malignancies clearly showed more favorable results in the Grafalon(R) group - Severe GvHD-free and relapse-free survival was 34% in the

Wuttisak Groups direction is to indicating to be a beauty and wellness Asias Heathcare—๒๓ มิ.ย. ๖๐

Wuttisak Group's direction is to indicating to be a beauty and wellness Asia's leader, expanding by franchise system and there are now morethan 50 prospect franchise units. Wuttisak Group makes the business clearly defined and bring out the strength of

อันฟอร์ส เรย์เซฟ เปิดตัวกล้อง RaySafe Pro-Slit มอบความแม่นยำในการวัดจุดโฟกัส Heathcare—๒๐ มิ.ย. ๖๐

อันฟอร์ส เรย์เซฟ (Unfors RaySafe) ผู้นำระดับโลกด้านโซลูชั่นการรับประกันคุณภาพเอกซเรย์ ประกาศเปิดตัวผลิตภัณฑ์ RaySafe Pro-Slit Phantom และ RaySafe Pro-Stand รูปภาพ - http://mma.prnewswire.com/media/525133/Fluke_Biomedical_Raysafe_Pro_Slit.jpg RaySafe

RaySafe Pro-Slit Camera Provides Accurate Focal Spot Measurement Heathcare—๒๐ มิ.ย. ๖๐

Unfors RaySafe, the global leader of X-ray quality assurance solutions introduces the RaySafe Pro-Slit Phantom and the RaySafe Pro-Stand. Photo - http://mma.prnewswire.com/media/525133/Fluke_Biomedical_Raysafe_Pro_Slit.jpg The RaySafe Pro-Slit Phantom

QIAGEN expands presence in Thailand to serve life sciences Heathcare—๑๖ มิ.ย. ๖๐

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced its expansion in Thailand and opened an office in Bangkok to enhance relationships with life science researchers and healthcare providers in the growing market. QIAGEN also announced

Swiss Tech Company Berlinger Special AG to Introduce a New Generation of its Universally-used Heathcare—๑๖ มิ.ย. ๖๐

Swiss technology company Berlinger Special AG has developed a totally new generation of the security bottles which it supplies for anti-doping testing worldwide over the past few months. The new "BEREG-KIT Geneva" security bottles are currently being

LEO Pharma Starts Phase 3 Clinical Study for Tralokinumab in Atopic Heathcare—๑๕ มิ.ย. ๖๐

LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that specifically targets the cytokine IL-13[1], which plays an important role in

Merck Awarded its First CRISPR Patent by Australian Patent Office Heathcare—๑๕ มิ.ย. ๖๐

- Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR - Similar patents pending in other countries; anticipate favorable outcomes , a leading science and technology company, today

Croma-Pharma Announces Two Major Milestones in China Heathcare—๑๔ มิ.ย. ๖๐

- Austria-based Croma-Pharma forms Joint Venture with Sihuan Pharmaceutical to market premium Intradermal-Filler in China, Hong Kong and Macao The registration of Princess(R) VOLUME and the signed Joint Venture open the fastest growing market for

Guger Technologies OG - mindBEAGLE: The First EEG-based BCI System Ever for Communication with Heathcare—๑๓ มิ.ย. ๖๐

Frontiers in Neuroscience recently published an article presenting mindBEAGLE as the very first and only EEG-based Brain-Computer Interface (BCI) that enables communication with patients who suffer from locked-in syndrome (LIS), complete locked-in

New LEADER Analysis Shows Victoza(R) Reduces Cardiovascular Risk in People With Type 2 Diabetes Heathcare—๑๓ มิ.ย. ๖๐

Findings from a post hoc analysis of the LEADER cardiovascular (CV) outcomes trial showed that treatment with Victoza(R) (liraglutide) resulted in similar reductions in the risk of major cardiovascular events in people with type 2 diabetes at high CV

Tresiba(R) Demonstrated No Increased Risk Of Major Cardiovascular Events and Significant Reduction Heathcare—๑๓ มิ.ย. ๖๐

Novo Nordisk today announced the primary results from DEVOTE - the first randomised, double-blind, treat-to-target, event-driven trial comparing two basal insulins, Tresiba(R) (insulin degludec injection 100 U/mL) and insulin glargine U100, in adults

Making a Dream Come True - Despite Hearing Loss, a Dancing Star is Born in Heathcare—๑๒ มิ.ย. ๖๐

Tianjiao Zhang is one of the best dancers in China. Despite her profound hearing loss, the 20-year-old artist is dancing at the highest level, and her moving story has been showcased by the Sonova Group : an emotional portrait in film about the young

Scientific Studies Addressing BGMS and CGM Accuracy Presented at the American Diabetes Heathcare—๑๒ มิ.ย. ๖๐

This week at the American Diabetes Association 77th Scientific Sessions, data were presented from three studies that assessed the accuracy and analytical performance of blood glucose monitoring systems (BGMS) and continuous glucose monitoring (CGM)

Switching to Tresiba(R) Provides Significant Reductions in Blood Glucose and Lower Rates of Heathcare—๑๒ มิ.ย. ๖๐

Findings from the real-world study, EU-TREAT (EUropean TREsiba AudiT), were presented today at the American Diabetes Association's 77th Scientific Sessions (ADA) in San Diego, US. The study showed that people with type 1 diabetes and type 2 diabetes